Biocon Ltd.

View in App
236.45 +3.30 ▲1.4%

29 November 2023, 04:01:00 PM
Volume: 189,824

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biocon.com
Market Cap 28,388.19 Cr.
Enterprise Value(EV) 44,223.09 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.15 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 56.96 Trailing Twelve Months Ending 2023-09
Industry PE 38.14 Trailing Twelve Months Ending 2023-09
Book Value / Share 158.10 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.50 Calculated using Price: 236.45
Dividend Yield 0.63 Period Ending 2023-03
No. of Shares Subscribed 120.06 Cr. 1,200,600,000 Shares
FaceValue 5
About Biocon Ltd.
The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Biocon Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Biocon Ltd. Performance

View details >>
1 Day
+1.42%
1 Week
+1.20%
1 Month
+6.17%
3 Month
-8.99%
6 Month
-1.21%
1 Year
-15.94%
2 Year
-34.80%
5 Year
-21.11%
10 Year
+264.55%

Biocon Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 17.22 16.91 15.74 9.17 18.01 14.26 12.03 9.83 4.98
Return on Capital Employed (%) 15.30 14.33 12.83 9.21 16.12 14.35 10.56 8.30 5.37
Return on Assets (%) 8.72 8.25 7.83 4.77 9.26 6.94 5.24 4.03 1.79

Biocon Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3,271 4,034 4,838 5,181 6,098 6,706 7,627 8,433 17,867 18,982
Non Curr. Liab. 1,378 2,421 2,305 2,007 2,122 2,685 5,497 6,803 20,742 19,554
Curr. Liab. 1,555 1,666 1,678 2,141 3,039 4,008 4,170 3,828 8,511 10,366
Minority Int. 172 266 376 468 609 677 881 1,038 4,622 5,295
Equity & Liab. 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 51,742 54,198
Non Curr. Assets 3,813 4,416 5,149 5,648 6,979 8,751 10,614 11,718 39,408 40,128
Curr. Assets 2,563 3,971 4,048 4,149 4,889 5,325 7,548 8,382 12,334 14,070
Misc. Exp. not W/O
Total Assets 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 51,742 54,198

Biocon Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 3,090 3,347 3,891 4,123 5,514 6,301 7,143 8,184 11,174 13,600
Other Income 53 84 157 206 414 508 605 690 768 485
Total Income 3,143 3,431 4,048 4,330 5,929 6,808 7,748 8,874 11,942 14,085
Total Expenditure -2,394 -2,584 -2,912 -3,294 -4,391 -5,044 -5,841 -6,691 -9,055 -10,502
PBIDT 749 847 1,137 1,035 1,538 1,765 1,907 2,183 2,888 3,583
Interest -9 -29 -26 -62 -71 -65 -58 -68 -419 -850
Depreciation -221 -249 -277 -385 -448 -552 -715 -814 -1,113 -1,412
Taxation -96 -142 -162 -157 -212 -315 -222 -212 -254 -154
Exceptional Items 105 161 195 68 13 -111 -291 -298
PAT 528 609 688 453 1,003 900 846 772 643 869
Minority Interest -31 -59 -76 -81 -97 -123 -106 -123 -180 -217
Share Associate -153
Other Related Items
Consolidated Net Profit 497 550 612 372 905 748 741 648 463 498
Adjusted EPS 4 5 5 3 8 6 6 5 4 4

Biocon Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 561 211 371 640 662 1,155 1,283 1,160 1,177 1,853
Cash Fr. Inv. -938 -509 -1,142 -499 -684 -714 -1,559 -3,625 -1,699 -14,282
Cash Fr. Finan. 426 186 1,068 -178 -240 -242 388 2,564 242 13,049
Net Change 49 -112 297 -36 -262 199 112 99 -280 619
Cash & Cash Eqvt 557 463 758 710 449 659 825 897 654 1,295

Biocon Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 60.64 60.64 60.64 60.64 60.64 60.64 60.64 60.64 60.64
Public 39.36 39.36 39.36 39.36 39.36 39.36 39.36 39.36 39.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Biocon Ltd. Announcements

View details >>
Wed, 29 Nov 2023
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Voting Results
Wed, 29 Nov 2023
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizers Report
Wed, 29 Nov 2023
Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Nicholas Robert Haggar (DIN:08518863) as an Independent Director of the Company not liable to retire by rotation for a term commencing from September 1 2023 till the conclusion of 48th Annual General Meeting to be held in the year 2026.

Biocon Ltd. Technical Scans

View details >>
Wed, 29 Nov 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Above Previous High Closing Above Previous High
High Increase in 1 Month High Increase in 1 Month

Biocon Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 288,124.14 1,202.20 +0.9%
Divi's Laboratories Ltd. 98,985.27 3,723.50 -0.9%
Cipla Ltd. 97,035.44 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. 95,335.50 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. 77,919.78 5,437.10 +1.3%
Mankind Pharma Ltd. 76,041.70 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. 70,779.09 2,089.90 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.70 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-09 74.33 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-09 28.10 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.73 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 111.72 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 59.32 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.06 2,089.90 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.82 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-09 7.81 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-09 3.91 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.74 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.99 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 9.02 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.55 2,089.90 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,089.90 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,089.90 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,089.90 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,089.90 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,089.90 +0.5%

Biocon Ltd. FAQ's

What is Biocon share price?
Can I buy Biocon shares now?
What is the Dividend Yield of Biocon?
What is the Market Cap of Biocon?
What are the key metrics to analyse Biocon?
What is the 52 Week High and Low of Biocon?
What is the trend of Biocon share price?